{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:09:14Z","timestamp":1781924954450,"version":"3.54.5"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["24621011"],"award-info":[{"award-number":["24621011"]}]},{"name":"Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173535","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T18:55:09Z","timestamp":1488826509000},"page":"e0173535","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study"],"prefix":"10.1371","volume":"12","author":[{"given":"Masayoshi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.sleep.2007.03.022","article-title":"Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute","volume":"8","author":"D Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group","volume":"14","author":"D Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.smrv.2009.11.006","article-title":"Dopaminergic augmentation of restless legs syndrome","volume":"14","author":"D Garcia-Borreguero","year":"2010","journal-title":"Sleep Med Rev"},{"issue":"Suppl","key":"ref4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1389-9457(02)00144-2","article-title":"Restless legs syndrome augmentation and pramipexole treatment","volume":"3","author":"L Ferini-Strambi","year":"2002","journal-title":"Sleep Med"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.sleep.2011.03.003","article-title":"Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample","volume":"12","author":"RP Allen","year":"2011","journal-title":"Sleep Med"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","article-title":"Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome","volume":"12","author":"B Hogl","year":"2011","journal-title":"Sleep Med"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"JW Winkelman","year":"2004","journal-title":"Sleep Med"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome: an extended study","volume":"26","author":"MH Silber","year":"2003","journal-title":"Sleep"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.sleep.2012.08.004","article-title":"Long-term use of pramipexole in the management of restless legs syndrome","volume":"13","author":"MC Lipford","year":"2012","journal-title":"Sleep Med"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"12","author":"N Silver","year":"2011","journal-title":"Sleep Med"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11325-014-1041-6","article-title":"Augmentation in restless legs syndrome patients in Korea","volume":"19","author":"JY Jeon","year":"2015","journal-title":"Sleep Breath"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"RP Allen","year":"2003","journal-title":"Sleep Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2377-11-28","article-title":"Algorithms for the diagnosis and treatment of restless legs syndrome in primary care","volume":"11","author":"D Garcia-Borreguero","year":"2011","journal-title":"BMC Neurol"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.sleep.2008.09.015","article-title":"The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics")","volume":"10","author":"WA Hening","year":"2009","journal-title":"Sleep Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrneurol.2015.122","article-title":"Restless legs syndrome-current therapies and management of augmentation","volume":"11","author":"C Trenkwalder","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/pcn.12074","article-title":"Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting","volume":"67","author":"Y Inoue","year":"2013","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.sleep.2007.03.023","article-title":"Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome","volume":"8","author":"D Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.sleep.2008.09.007","article-title":"The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels","volume":"10","author":"B Frauscher","year":"2009","journal-title":"Sleep Med"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.sleep.2007.07.020","article-title":"Augmentation in restless legs syndrome is associated with low ferritin","volume":"9","author":"C Trenkwalder","year":"2008","journal-title":"Sleep Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:00:05Z","timestamp":1588989605000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173535"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Romigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173535","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}